- Injective is gearing up for a big move as it nears $16.42 resistance with strong chart patterns backing a bullish breakout.
- Bitcoin’s surge past $122K is giving Injective the perfect setup to rally after months of quiet sideways trading.
- Falling trading volume and tightening price action suggest Injective could soon make a strong upward move if momentum holds.
Injective (INJ) is flashing a potential breakout as Bitcoin smashes through the 1.618 Fibonacci extension at $122,235. Traders are on high alert because INJ is showing an inverse head-and-shoulders pattern alongside a symmetrical triangle, signaling a bullish reversal.
As per Crypto analyst Cryptobusy, the neckline rests near $16.42, and a confirmed breakout could trigger a strong rally. This setup comes after months of consolidation, with the asset bouncing from a $6–$7 base. Bitcoin’s rally has created a bullish backdrop, which could help INJ accelerate if momentum holds.
Besides, the INJ symmetrical triangle has been forming since its sharp drop from over $30. The pattern shows converging trendlines, with higher lows meeting lower highs. This indicates reduced volatility and possible accumulation.
Source: CryptoBusy
Moreover, trading volume has gradually declined, which often happens before explosive moves. The apex of the pattern is approaching, meaning a decisive breakout is likely very soon.
Technical Signals Align for Injective
Additionally, the inverse head-and-shoulders formation is reinforcing bullish sentiment. The neckline at $16.42 is the key barrier for buyers. If price pushes above it, traders could target significantly higher levels.
Higher lows along the ascending support trendline show sustained buying interest. However, a drop below support could invalidate the bullish scenario, so risk management is critical.
Bitcoin’s surge is another factor to watch. It has rocketed from around $15,000 to over $120,000 in this cycle, delivering more than 700% gains. It has also cleared major Fibonacci levels, including the key $81,368 mark.
Source: Trireme
Now, with $122,235 reached, traders expect either a short-term consolidation or continued upside. Institutional demand is outpacing new supply at a ratio of 5.6:1 this year, which keeps upward pressure strong.
